Kathryn M. Connor, MD, MHS
- 9Articles
- 24.3KReads1
- 1998–2008Active
- 19Collaborators
- 9Citations2
About
Kathryn M. Connor, MD, MHS, has published extensively on the clinical management of posttraumatic stress disorder, including pharmacologic augmentation strategies for treatment-resistant cases. Her work also addresses anxiety disorders, major depressive disorder, and obsessive-compulsive and related disorders, with studies on medications such as risperidone, paroxetine, aripiprazole, and bupropion. Connor has contributed to research on the assessment of resilience following trauma and the evaluation of mental health after mass disasters.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
